Onabotulinumtoxina + Botulinum Toxin Type A Interaction
Majorinteraction on record
Description
Administration at the same time or within several months may cause excessive neuromuscular weakness. Effect is unknown and weakness may be exacerbated.
Mechanism
Additive neuromuscular blocking effects
Source: NLP:onabotulinumtoxina